Literature DB >> 2942685

Alpha 2-plasmin inhibitor-plasmin complexes in synovial fluid.

R D Inman, P C Harpel.   

Abstract

The role of the fibrinolytic enzyme system in inflammatory joint disease has been addressed by several experimental approaches. In our study we examined synovial fluid (SF) in several different diseases for alpha 2-plasmin inhibitor-plasmin complexes by an enzyme linked immunosorbent assay (ELISA). These complexes are present in both rheumatoid and nonrheumatoid SF, with highest levels seen in septic arthritis. Thus the plasminogen system is intact in inflammatory SF, and plasmin may play a role in the local inflammatory process.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2942685

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  4 in total

1.  Comparison of pancreas juice proteins from cancer versus pancreatitis using quantitative proteomic analysis.

Authors:  Ru Chen; Sheng Pan; Kelly Cooke; Kara White Moyes; Mary P Bronner; David R Goodlett; Ruedi Aebersold; Teresa A Brentnall
Journal:  Pancreas       Date:  2007-01       Impact factor: 3.327

2.  Thrombin receptor mediated signals induce expressions of interleukin 6 and granulocyte colony stimulating factor via NF-kappa B activation in synovial fibroblasts.

Authors:  H Shin; I Kitajima; T Nakajima; Q Shao; T Tokioka; I Takasaki; N Hanyu; T Kubo; I Maruyama
Journal:  Ann Rheum Dis       Date:  1999-01       Impact factor: 19.103

3.  Cerebrospinal fluid activity of tissue plasminogen activator in patients with neurological diseases.

Authors:  F O Akenami; V Sirén; M Koskiniemi; M A Siimes; H Teräväinen; A Vaheri
Journal:  J Clin Pathol       Date:  1996-07       Impact factor: 3.411

4.  A comparative proteomics study of a synovial cell line stimulated with TNF-α.

Authors:  Seiji Shibasaki; Miki Karasaki; Shunsuke Aburaya; Hironobu Morisaka; Yumiko Takeda; Wataru Aoki; Sachie Kitano; Masayasu Kitano; Mitsuyoshi Ueda; Hajime Sano; Tsuyoshi Iwasaki
Journal:  FEBS Open Bio       Date:  2016-03-31       Impact factor: 2.693

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.